Phase I trial evaluating MEK inhibitor selumetinib with concomitant thoracic radiotherapy in NSCLC

Radiotherapy and Oncology(2018)

Cited 0|Views44
No score
Key words
mek inhibitor selumetinib,concomitant thoracic radiotherapy,nsclc
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined